search
Back to results

A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Written and verbal patient education on hypertension and its treatment
Sponsored by
University of Warwick
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

1)18 or over 2) male or female 3) Have been started on any blood pressure medication

Exclusion Criteria:

1)Patients with English language problems

Sites / Locations

  • J P Goes chemist

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Usual pharmacy care

usual pharmacy care plus structured information

Arm Description

Participants will not receive any structured written education on hypertension and its treatment

Participants will be provided with validated verbal and written information on hypertension and its treatment, including information about class (es) of anti-hypertensive medication(s) used by each patient, and their common side-effects. The written material will be based on validated patient information leaflets from the British Heart Foundation and the Blood Pressure Association.

Outcomes

Primary Outcome Measures

Changes in systolic or diastolic blood pressure
Systolic and diastolic blood pressure will be measured and recorded in mm Hg using OMRON blood pressure monitors

Secondary Outcome Measures

change in the knowledge of hypertension

Full Information

First Posted
September 3, 2013
Last Updated
December 4, 2017
Sponsor
University of Warwick
search

1. Study Identification

Unique Protocol Identification Number
NCT01939860
Brief Title
A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
January 2014 (Actual)
Primary Completion Date
June 2014 (Actual)
Study Completion Date
June 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Warwick

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Hypertension is a major health problem, however its control is unsatisfactory. One of the reasons for such a high prevalence of this disease includes poor patient compliance to treatment. Approximately 30 % of newly diagnosed hypertensive patients stop taking their blood pressure medication by six months and 50% by 12 months. The UK government is keen to encourage community pharmacists to play an active role in participation of services that can improve patient adherence to their medications. The New Medicines Service (NMS) and targeted Medicines Use Reviews (MUR) are established services which fund community pharmacists to review and explain medicine use to patients, with hypertension a common condition for which advice is given within these schemes. Within these schemes, advice is verbal and unstructured, with no specific written information provided on drugs or the disease being treated. This study aims to determine whether structured information provided to participants verbally and in writing by community pharmacists about blood pressure and current medicine(s) within NMS and targeted MURs will be retained and will be associated with improved hypertension control. Participants will be recruited from people eligible for NMS and MURs and attending community pharmacies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
56 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual pharmacy care
Arm Type
No Intervention
Arm Description
Participants will not receive any structured written education on hypertension and its treatment
Arm Title
usual pharmacy care plus structured information
Arm Type
Experimental
Arm Description
Participants will be provided with validated verbal and written information on hypertension and its treatment, including information about class (es) of anti-hypertensive medication(s) used by each patient, and their common side-effects. The written material will be based on validated patient information leaflets from the British Heart Foundation and the Blood Pressure Association.
Intervention Type
Other
Intervention Name(s)
Written and verbal patient education on hypertension and its treatment
Primary Outcome Measure Information:
Title
Changes in systolic or diastolic blood pressure
Description
Systolic and diastolic blood pressure will be measured and recorded in mm Hg using OMRON blood pressure monitors
Time Frame
1 year (trial would be stopped at 26 weeks if it is not possible to recruit any further participants
Secondary Outcome Measure Information:
Title
change in the knowledge of hypertension
Time Frame
one year(trial would be stopped at 26 weeks if it is not possible to recruit any further participants)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 1)18 or over 2) male or female 3) Have been started on any blood pressure medication Exclusion Criteria: 1)Patients with English language problems
Facility Information:
Facility Name
J P Goes chemist
City
Coventry
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment

We'll reach out to this number within 24 hrs